ArticleNanoscale advances2019
Quantum Dot Cellular Uptake and Toxicity in the Developing Brain: Implications for Use as Imaging Probes.
Article in Nanoscale advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 53 citations in OpenAlex.
- Article
- From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer's Disease Landscape.Medicina (Kaunas, Lithuania) · 2025Review
- Carbon dot-ZIF-67-infused tragacanth hydrogel films: leveraging tunable luminescence through displacement mechanisms for anthrax detection.Mikrochimica acta · 2025Article
- Application of quantum dots in brain diseases and their neurotoxic mechanism.Nanoscale advances · 2024Review
- Highly Monodisperse, Size Tunable Glucosamine Conjugated CdSe Quantum Dots for Enhanced Cellular Uptake and Bioimaging.ACS omega · 2024Article
- Nanotherapeutics and the Brain.Annual review of chemical and biomolecular engineering · 2022Review
- Analysis of Nanomaterials on Biological and Environmental Systems and New Analytical Methods for Improved Detection.International journal of molecular sciences · 2022Article
- Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology.International journal of molecular sciences · 2022Review
- Effect of Particle Size and Surface Charge on Nanoparticles Diffusion in the Brain White Matter.Pharmaceutical research · 2022Article
- Functionalized Nanomaterials as Tailored Theranostic Agents in Brain Imaging.Nanomaterials (Basel, Switzerland) · 2021Review
- Crossing the blood-brain barrier with carbon dots: uptake mechanism andNanoscale advances · 2021Article
- Multiple Particle Tracking Detects Changes in Brain Extracellular Matrix and Predicts Neurodevelopmental Age.ACS nano · 2021Article
- Advances in Drug Delivery Nanosystems Using Graphene-Based Materials and Carbon Nanotubes.Materials (Basel, Switzerland) · 2021Review
- CdSe/ZnS Core-Shell-Type Quantum Dot Nanoparticles Disrupt the Cellular Homeostasis in Cellular Blood-Brain Barrier Models.International journal of molecular sciences · 2021Article
- Governing Transport Principles for Nanotherapeutic Application in the Brain.Current opinion in chemical engineering · 2020Article
- Nanoparticle-microglial interaction in the ischemic brain is modulated by injury duration and treatment.Bioengineering & translational medicine · 2020Article
- Monolayer Quantum-Dot Based Light-Sensor by a Photo-Electrochemical Mechanism.Micromachines · 2020Article
- Quantum Dot Labeling and Visualization of Extracellular Vesicles.ACS applied nano materials · 2020Article
- Ligand-conjugated quantum dots for fast sub-diffraction protein tracking in acute brain slices.Biomaterials science · 2020Article
- The Biological Activity Research of the Nano-Drugs Based on 5-Fluorouracil-Modified Quantum Dots.International journal of nanomedicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
Abstract
Nanometer-sized luminescent semiconductor quantum dots (QDs) have been utilized as imaging and therapeutic agents in a variety of disease settings, including diseases of the central nervous system. QDs have several advantages over traditional fluorescent probes including their small size (5-10 nm), tunable excitation and emission spectra, tailorable surface functionality, efficient photoluminescence, and robust photostability, which are ideal characteristics for
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.